Henrietta Lacks: The Woman Whose Cells Changed Medical History
PHOTO BY KOST9N4 ON PIXABAY
Henrietta Lacks is often referred to as the woman whose cells revolutionized medical research. Her cells, known as HeLa cells, became instrumental in developing vaccines, cancer treatments, and advances in genetics.
Lacks’s story intersects with themes of ethics, race, and medical innovation, sparking conversations that are still relevant today. Understanding her impact sheds light on both the triumphs and challenges within modern medicine.
The Woman Behind the HeLa Cells
Henrietta Lacks was born in 1920 in Roanoke, Virginia, and raised in a poor African American family. In 1951, she sought treatment for cervical cancer at Johns Hopkins Hospital.
Doctors took a sample of her tumor without her consent. Her cells, later named HeLa, became the first immortal human cell line and were vital to breakthroughs like the polio vaccine and cancer research.
Lacks died later that year, but her legacy lives on. Her story continues to shape conversations about ethics and patient rights.
Get to know Lacks a little more by watching the video below:
How One Cell Line Transformed Science
HeLa cells, taken from Henrietta Lacks in 1951, were the first immortal human cell line. They divide endlessly in labs and have advanced research in cancer, vaccines, and genetics.
Researchers still use HeLa cells to study how cells function. One Instagram post shows their structure, highlighting actin filaments, microtubules, and proteins like Myosin 15, which is key to human hearing:
These cells have made complex studies possible and remain vital in understanding disease. Their impact continues across science and medicine today.
The Legacy and the Ethical Debate
Henrietta Lacks left a legacy that transformed medicine—but it began without her consent. Her HeLa cells, taken unknowingly during cancer treatment, became the first immortal human cell line.
As shown in the Instagram post below, HeLa cells led to breakthroughs in cancer research, vaccines, IVF, and more. Yet her family saw none of the benefits for decades:
Her case sparked major ethical debates about consent, patient rights, and racial injustice in research—conversations that continue to shape medical policy today.